We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · December 02, 2019

Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke

JAMA Neurology

 

Additional Info

JAMA Neurology
Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study
JAMA Neurol 2019 Oct 01;76(10)1192-1202, Y Xian, H Xu, EC O'Brien, S Shah, L Thomas, MJ Pencina, GC Fonarow, DM Olson, LH Schwamm, DL Bhatt, EE Smith, D Hannah, L Maisch, BL Lytle, ED Peterson, AF Hernandez

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading